The present invention relates to compounds of formula (I) wherein R1, R2, x, X, Y and B are as defined in the description for the treatment of muscarinic acetylcholine receptor mediated diseases, in particular M3 muscarinic receptor mediated diseases.
本发明涉及式(I)的化合物,其中R1,R2,x,X,Y和B如所述的描述中所定义,用于治疗肌肉型
乙酰胆碱受体介导的疾病,特别是M3肌肉型受体介导的疾病。